CSCI
COSCIENS Biopharma Inc. Common Stock
CSCI
CSCI
Delisted
CSCI was delisted on the 3rd of September, 2025.
26 hedge funds and large institutions have $10.6M invested in COSCIENS Biopharma Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 11 increasing their positions, 2 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
8% more funds holding
Funds holding: 24 → 26 (+2)
0.02% less ownership
Funds ownership: 0.15% → 0.14% (-0.02%)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
26
Holding in Top 10
–
Calls
$402K
Puts
$140K
Top Buyers
| 1 | +$1.03M | |
| 2 | +$795K | |
| 3 | +$568K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$424K |
| 5 |
Renaissance Technologies
New York
|
+$358K |
Top Sellers
| 1 | -$2.9M | |
| 2 | -$987K | |
| 3 | -$326K | |
| 4 |
AAP
Ardsley Advisory Partners
Stamford,
Connecticut
|
-$74K |
| 5 |
Jane Street
New York
|
-$30K |